Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,678 | 60 | 89.1% |
| Education | $205.36 | 5 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $360.37 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $284.44 | 5 | $0 (2023) |
| NxStage Medical, Inc. | $263.10 | 4 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $232.50 | 8 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $118.81 | 1 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $114.84 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $107.70 | 1 | $0 (2017) |
| Medtronic Vascular, Inc. | $63.68 | 1 | $0 (2019) |
| Amgen Inc. | $60.15 | 3 | $0 (2021) |
| Aurinia Pharma U.S., Inc. | $50.14 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $130.81 | 7 | Aurinia Pharma U.S., Inc. ($50.14) |
| 2023 | $183.50 | 5 | AstraZeneca Pharmaceuticals LP ($110.29) |
| 2022 | $214.81 | 7 | AstraZeneca Pharmaceuticals LP ($118.71) |
| 2021 | $103.88 | 7 | Fresenius USA Marketing, Inc. ($41.13) |
| 2020 | $213.56 | 7 | Janssen Pharmaceuticals, Inc ($118.81) |
| 2019 | $337.77 | 9 | Mallinckrodt Enterprises LLC ($165.44) |
| 2018 | $273.03 | 11 | NxStage Medical, Inc. ($75.00) |
| 2017 | $425.58 | 12 | NxStage Medical, Inc. ($188.10) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Catheter Lock Solution | ||||||
| 08/07/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/09/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: NEPHROLOGY | ||||||
| 04/24/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/07/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/25/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 11/14/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $110.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/31/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/28/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/21/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/28/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/26/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/28/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/01/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $25.08 | General |
| 01/18/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/03/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/14/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Phosphate binder for ESRD | ||||||
| 04/15/2021 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Nephrology | ||||||
| 04/06/2021 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/30/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/25/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 750 | 2,276 | $378,975 | $192,027 |
| 2022 | 9 | 710 | 2,118 | $356,450 | $179,069 |
| 2021 | 9 | 688 | 2,813 | $484,325 | $228,174 |
| 2020 | 10 | 753 | 3,747 | $783,025 | $322,309 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 148 | 1,165 | $145,625 | $67,815 | 46.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 259 | 455 | $56,875 | $37,826 | 66.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 232 | $46,400 | $20,471 | 44.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 24 | 87 | $43,500 | $18,774 | 43.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 121 | 139 | $31,275 | $17,429 | 55.7% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 30 | 104 | $26,000 | $15,539 | 59.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 72 | 72 | $21,600 | $10,690 | 49.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 22 | $7,700 | $3,484 | 45.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 138 | 1,028 | $128,500 | $54,872 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 230 | 388 | $48,500 | $32,694 | 67.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 133 | 152 | $34,200 | $22,262 | 65.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 274 | $54,800 | $20,997 | 38.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 21 | 79 | $39,500 | $17,844 | 45.2% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 31 | 108 | $27,000 | $16,730 | 62.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 57 | 57 | $14,850 | $8,863 | 59.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 13 | 20 | $7,000 | $3,302 | 47.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,100 | $1,505 | 71.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 141 | 1,768 | $221,000 | $95,670 | 43.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 200 | 326 | $40,750 | $27,305 | 67.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 21 | 97 | $67,900 | $26,054 | 38.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 87 | 262 | $52,400 | $20,283 | 38.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 121 | 133 | $29,925 | $19,926 | 66.6% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 29 | 102 | $25,500 | $15,816 | 62.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 27 | 52 | $26,000 | $11,602 | 44.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 47 | 47 | $11,750 | $7,162 | 61.0% |
About Dr. Mark Shermer, MD
Dr. Mark Shermer, MD is a Nephrology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144306366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Shermer, MD has received a total of $1,883 in payments from pharmaceutical and medical device companies, with $130.81 received in 2024. These payments were reported across 65 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,678).
As a Medicare-enrolled provider, Shermer has provided services to 2,901 Medicare beneficiaries, totaling 10,954 services with total Medicare billing of $921,579. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Memphis, TN
- Active Since 10/31/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1144306366
Products in Payments
- Velphoro (Drug) $329.72
- System One (Device) $263.10
- ACTHAR (Biological) $232.50
- LOKELMA (Drug) $165.73
- INVOKANA (Drug) $118.81
- FARXIGA (Drug) $118.71
- PRALUENT (Drug) $107.70
- Reveal LINQ (Device) $63.68
- SAMSCA (Drug) $61.20
- Veltassa (Drug) $60.13
- JYNARQUE (Drug) $53.64
- LUPKYNIS (Drug) $50.14
- Aquadex (Device) $46.66
- Parsabiv (Biological) $43.78
- BENLYSTA (Biological) $40.31
- DefenCath (Drug) $19.43
- ZEPATIER (Drug) $17.61
- Parsabiv (Drug) $16.37
- Not Product Related (Medical Supply) $15.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Memphis
Dr. Omar Davis, M.d, M.D
Nephrology — Payments: $57,405
Dr. Natarsha Grant, Md, MD
Nephrology — Payments: $34,340
Dr. Robert Canada, Md, MD
Nephrology — Payments: $21,903
Dr. Wael Hussein
Nephrology — Payments: $15,498
Minesh Pathak, M.d, M.D
Nephrology — Payments: $13,583
L Quarles, M.d, M.D
Nephrology — Payments: $12,060